Any pause in taking the osteoporosis drug risedronate (Actonel) should last no longer than 2 years rather than the 2 to 3 years currently recommended for bisphosphonates, new research suggests. In a cohort of patients aged 66 and older in Ontario, Canada, those who had been taking risedronate had a 34% greater risk of a […]
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. In the study, published July 29 in Nature Communications, investigators discovered that mice lacking the cellular protein SLITRK5, found on the surface of […]
Five years of treatment with bisphosphonates after chemotherapy for high-risk early breast cancer is too much, say researchers reporting new results from a phase 3 trial with almost 3000 women. Current guidelines call for 3 to 5 years of bisphosphonate therapy on the theory that these drugs might reduce breast cancer recurrence as well as […]
Osteoporosis is a condition that does not exhibit symptoms until there is a bone fracture, so a large percentage of patients remain unaware of their condition. When people are unaware their bones have weakened, the condition is left untreated, and the recent rise of the elderly population has caused an increase in bone fractures. This […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. HYSONE contains the active ingredient hydrocortisone CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Hysone. It does not contain all of the available information. It does not take the place of talking to your doctor […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EVIFYNE® V11219 Raloxifene hydrochloride Consumer Medicine Information What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine.It does not contain all the available information and does not take the place of […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MADOPAR 190718 (levodopa and benserazide) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Madopar tablets and capsules. It does not contain all the available information. It does not take the place of talking to your […]
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. The work is supported by the National Institutes of Health and is published in Biophysical Journal. Purdue University innovators developed a stabilized form of human calcitonin, which is a […]
A new study reveals that many older men who experience a fracture are still underdiagnosed with and undertreated for osteoporosis. Details of the study was presented at ACR Convergence, the American College Rheumatology’s annual meeting (ABSTRACT #0533). Osteoporosis is a common condition that results from a loss of bone mass, measured as bone density, and […]
The osteoporosis wonder drug that helps rebuild crumbling bones and could save 500,000 people a year a visit to the fracture clinic More than three million Britons suffer from the brittle bone disease osteoporosis Some 500,000 osteoporosis sufferers are treated in hospital a year for fractures The condition often goes undetected until a sufferer starts […]
